Development of a quantitative-PCR method for specific FLT3/ITD monitoring in acute myeloid leukemia
- 17 June 2004
- journal article
- Published by Springer Nature in Leukemia
- Vol. 18 (8) , 1441-1444
- https://doi.org/10.1038/sj.leu.2403409
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- The role of FLT3 in haematopoietic malignanciesNature Reviews Cancer, 2003
- Clonality profile in relapsed precursor-B-ALL children by GeneScan and sequencing analyses. Consequences on minimal residual disease monitoringLeukemia, 2003
- Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspectsLeukemia, 2003
- Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in leukemogenesis, minimal residual disease detection, and possible therapy with FLT3 inhibitorsBlood, 2002
- Internal tandem duplication of FLT3 in relapsed acute myeloid leukemia: a comparative analysis of bone marrow samples from 108 adult patients at diagnosis and relapseBlood, 2002
- Murky waters for MRD detection in AML: flightyFLT3/ITDsBlood, 2002
- Minimal residual disease in acute myeloid leukaemiaBest Practice & Research Clinical Haematology, 2002
- Quantitative, real-time polymerase chain reactions for FLT3 internal tandem duplications are highly sensitive and specificLeukemia Research, 2001
- Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual diseaseLeukemia, 1999